4//SEC Filing
Sendek Joel 4
Accession 0000899243-18-019567
CIK 0001701108other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 9:44 PM ET
Size
9.3 KB
Accession
0000899243-18-019567
Insider Transaction Report
Form 4
Sendek Joel
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-07-05$5.90/sh+2,000$11,800→ 17,181 total - Sale
Common Stock
2018-07-05$17.50/sh−2,000$35,000→ 15,181 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-07-05−2,000→ 165,833 totalExercise: $5.90Exp: 2027-07-05→ Common Stock (2,000 underlying)
Footnotes (3)
- [F1]The option exercises and related sales reported in this Form 4 were made pursuant to a Rule 10b5-1 trading plan previously entered into by the Reporting Person in December 2017.
- [F2]Amount includes 10,181 shares of common stock held by the Joel D. Sendek Retained Annuity Trust No. 1, of which the Reporting Person is a trustee.
- [F3]The shares underlying this option vested as to 25% on May 1, 2018, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001720875
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 9:44 PM ET
- Size
- 9.3 KB